Résultat correspond à votre recherche
-
Glibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes.
Michel Polak, Jacques Beltrand
Source : Pediatr Diabetes
2019 oct 28
Pmid / DOI: 30684309
-
Michel Polak, Athanasia Stoupa
Source : Lancet Diabetes Endocrinol
2019 aoû 23
Pmid / DOI: 31377265
-
TUBB1 mutations cause thyroid dysgenesis associated with abnormal platelet physiology.
Aurore Carre
Source : EMBO Mol Med
2019 juil 22
Pmid / DOI: 30446499
-
Michel Polak, Jacques Beltrand
Source : Lancet Diabetes Endocrinol
2019 juin 11
Pmid / DOI: 29880308
-
Thyroid Hypoplasia in Congenital Hypothyroidism Associated with Thyroid Peroxidase Mutations.
Aurore Carre, Athanasia Stoupa, Michel Polak
Source : Thyroid
2019 mar 21
Pmid / DOI: 29790453
-
Update of Thyroid Developmental Genes.
Michel Polak, Athanasia Stoupa, Dulanjalee Kariyawasam, Aurore Carre
Source : Endocrinol. Metab. Clin. North Am.
2018 mai 4
Pmid / DOI: 27241962
-
Mutations in BOREALIN cause thyroid dysgenesis.
Michel Polak, Aurore Carre, Athanasia Stoupa, Dulanjalee Kariyawasam
Source : Hum. Mol. Genet.
2017 sep 15
Pmid / DOI: 28025328
-
Michel Polak, Jacques Beltrand
Source : Diabetes Care
2016 juin 6
Pmid / DOI: 26438614
-
RFX6 regulates insulin secretion by modulating Ca2+ homeostasis in human β cells.
Michel Polak
Source : Cell Rep
2015 juil 24
Pmid / DOI: 25497100
-
DYRK1A BAC transgenic mouse: a new model of thyroid dysgenesis in Down syndrome.
Michel Polak, Dulanjalee Kariyawasam, Aurore Carre
Source : Endocrinology
2015 avr 29
Pmid / DOI: 25490145